Management of Hyponatremia
The management of hyponatremia should be based on volume status assessment, severity of symptoms, and rate of sodium correction, with fluid restriction to 1,000 mL/day recommended for moderate hyponatremia (120-125 mEq/L) and more severe fluid restriction with albumin infusion for severe hyponatremia (<120 mEq/L). 1
Classification and Assessment
Hyponatremia is classified by severity:
- Mild: 126-135 mEq/L
- Moderate: 120-125 mEq/L
- Severe: <120 mEq/L 2
And by volume status:
- Hypovolemic: Urine osmolality variable, urine sodium <20 mEq/L
- Euvolemic: Urine osmolality >500 mOsm/kg, urine sodium >20-40 mEq/L
- Hypervolemic: Elevated urine osmolality, urine sodium <20 mEq/L 1
Management Algorithm Based on Volume Status
1. Hypovolemic Hyponatremia
- First-line treatment: Discontinue diuretics/laxatives and provide fluid resuscitation
- Preferred fluids: 5% IV albumin or crystalloid (preferentially lactated Ringer's) 2
- Monitoring: Check serum sodium levels every 2-4 hours initially 1
2. Euvolemic Hyponatremia
- First-line treatment: Address underlying cause (e.g., SIADH, medications, hypothyroidism)
- Fluid management: Restrict fluid intake (500-1000 mL/day)
- Refractory cases: Consider urea, salt tablets, or vasopressin receptor antagonists 1
- For SIADH: Fluid restriction is the mainstay of treatment 3
3. Hypervolemic Hyponatremia
- For moderate hyponatremia (120-125 mEq/L): Fluid restriction to 1,000 mL/day
- For severe hyponatremia (<120 mEq/L): More severe fluid restriction with albumin infusion
- Additional measures: Treat underlying condition (heart failure, cirrhosis) 2, 1
Correction Rates and Monitoring
- Target initial correction for severe symptomatic hyponatremia: 4-6 mEq/L within 1-2 hours to reverse neurological symptoms 1
- Maximum safe correction: 10-12 mEq/L in any 24-hour period 1, 3
- For high-risk patients (alcoholism, malnutrition, liver disease): Limit to 4-6 mEq/L per day 1
- Monitoring frequency:
- Every 2-4 hours initially
- Every 4-6 hours during active correction
- 1-2 weeks after initiation, then monthly for first 3 months 1
Special Considerations for Severe Symptomatic Hyponatremia
For patients with severe symptoms (somnolence, seizures, coma):
- Emergency treatment: 3% hypertonic saline to increase serum sodium by 4-6 mEq/L within 1-2 hours 3
- Initial infusion rate calculation: Body weight (kg) × desired rate of increase in sodium (mmol/L per hour) 4
- Caution: Overly rapid correction (>12 mmol/L per 24 hours) may cause osmotic demyelination syndrome (ODS) 4, 1
Pharmacological Options
Vasopressin Receptor Antagonists (Vaptans)
- Indication: Short-term use (≤30 days) for persistent euvolemic or hypervolemic hyponatremia 1
- Starting dose: Tolvaptan 15 mg once daily 5
- Efficacy: Tolvaptan significantly increases serum sodium levels compared to placebo (4.0 vs 0.4 mEq/L at Day 4) 5
- Contraindications: Avoid with strong CYP3A inhibitors 5
- Monitoring: Regular serum sodium checks to prevent overly rapid correction 5
- Caution: Risk of gastrointestinal bleeding in patients with cirrhosis (10% vs 2% with placebo) 5
Complications and Risks
- Hyponatremia in cirrhosis increases risk of hepatic encephalopathy (OR 3.4), hepatorenal syndrome (OR 3.5), and spontaneous bacterial peritonitis (OR 2.4) 2
- Even mild hyponatremia is associated with cognitive impairment, gait disturbances, and increased rates of falls and fractures 3
- Osmotic demyelination syndrome can result from overly rapid correction of chronic hyponatremia 3
Key Pitfalls to Avoid
- Overcorrection: Never exceed 10-12 mEq/L in 24 hours to prevent osmotic demyelination syndrome
- Inadequate monitoring: Frequent sodium checks are essential during correction
- Ignoring volume status: Treatment approach differs significantly based on volume assessment
- Treating numbers, not patients: Mild asymptomatic hyponatremia often requires only monitoring and minimal intervention
- Failing to identify and treat underlying causes: Address the primary condition causing hyponatremia
The management of hyponatremia requires careful assessment of volume status, appropriate correction rates, and vigilant monitoring to prevent complications while effectively treating this common electrolyte disorder.